Business Wire

TomTom and ASAP Collaborate on Deploying the TomTom BRIDGE in Utilities Sector

8.10.2015 05:30 | Business Wire

Del

TomTom (TOM2), a global leader in navigation and mapping products, and ASAP, a Field Force Automation provider, today announce a cooperation to integrate and sell OMOGEN for Field Forces, based on TomTom’s BRIDGE solution. TomTom BRIDGE is a hardware platform that seamlessly connects business applications with TomTom technology.

OMOGEN is an easy and fully configurable application that provides support for custom forms, photos, signature capture, RFID and more – also accessible from the back end.

Thierry FOLLIOT, ASAP President, said: “We provide SARP, Groupe Veolia, with OMOGEN, a full Field Force Automation suite for managing mobile workers and back offices, in order to provide the highest quality service. The customer was looking for a reliable device, with a comfortable screen size, for intense usage of the OMOGEN application in their trucks. In this tough environment, the TomTom BRIDGE delivers an innovative, reliable and robust solution. Thanks to an Android environment, and to TomTom’s expertise, we have quickly and efficiently integrated OMOGEN on the TomTom BRIDGE.”

Sebastien Ruffino, VP Sales, B2B Products, TomTom, said: “That the leading sanitation company in France has chosen TomTom BRIDGE for its field force, cements our conviction that the BRIDGE is the ideal device for tough environments. Our solution will help these maintenance people on the move to get access to the right information, at the right time. The TomTom BRIDGE is a fantastic platform for this vertical – helping businesses to work more efficiently, having all they need on one device.”

-Ends-

Notes to Editors

About OMOGEN

- OMOGEN, developed by ASAP, is the new brand announced 1st October that takes benefits of various Guygle usage.

- OMOGEN allows a back office to prepare, plan and dispatch work orders to field workers in different vertical segments: utilities, maintenance, Care and Repair, B2B service.

- OMOGEN easily allows the planning of specific campaigns for preventive maintenance, and the collection of data for managing assets and providing a quality service to the end user.

- OMOGEN allows field workers to receive, document and send back tailored reports.

- The mobile worker can document, take pictures, read barcodes, RFID, and capture signatures.

- OMOGEN integrates full functionalities to track and trace vehicles, staff and other assets.

- The Field Worker can take the TomTom BRIDGE outside the truck cabin to further use OMOGEN.

About TomTom

At TomTom (TOM2) our mission is to make technology so easy to use, that everyone can benefit from it.

We created easy to use navigation devices, helping millions of people to get where they want to be. Today, we continue to simplify the complex, making technology more accessible for everyone.

We have four customer facing business units: Consumer, Telematics, Automotive and Licensing.

We make easy to use navigation devices, sport watches and action cameras for consumers. We enable businesses with vehicles to more easily manage and improve fleet efficiency whilst increasing overall business performance with our Telematics solutions. We also offer a world leading real-time map platform that is powering innovative location based services and helping to make automated driving a reality for the automotive industry.

Founded in 1991 and headquartered in Amsterdam, we have 4,200 employees worldwide and sell our products in over 46 countries.

About ASAP

ASAP guaranties robust commitments, agile approach to projects. We manage projects for various company sizes, from SMEs to Worldwide groups, affiliates, divisions.

Our various installed base requires multiple skills, expertizes and resources to be able to manage, maintain and grow. As a result, all those experiences, cases, customer queries allow ASAP to be responsive and reactive to a large range of new projects.

We propose high level IT Services as technical support for users & infrastructure, IT engineering, software development for web & mobile and hosting services as Private & Hybrid Cloud, DRP, Remote backups, etc. OMOGEN is hosted on our infrastructure in France in EQUINIX datacenters.

Contact information

TomTom Global Press Office:
Greg Morrison
Global PR Manager
greg.morrison@tomtom.com
or
Investor Relations:
Bisera Grubesic
Head of Investor Relations and Treasury
+31 (0)20 757 5194
ir@tomtom.com
or
ASAP Press Office:
Sabrina LENOGUE
Communication
Tél : 01 56 05 61 57
Sabrina.LENOGUE@asap-info.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom